Faithful Pharmacy

Mounjaro 2.5 mg, containing tirzepatide, is used to improve blood sugar control in adults with type 2 diabetes and supports weight management in obese or overweight individuals, always alongside diet and exercise; it mimics natural hormones (GIP/GLP-1) to increase insulin, decrease appetite, slow digestion, and reduce sugar production, making it effective for metabolic health. The starting dose is 2.5 mg weekly, gradually increased for better control, but it's not for type 1 diabetes or diabetic ketoacidosis. 

Mounjaro 5 mg, containing tirzepatide, is used to improve blood sugar control in adults with type 2 diabetes and supports weight management in obese or overweight individuals, always alongside diet and exercise; it mimics natural hormones (GIP/GLP-1) to increase insulin, decrease appetite, slow digestion, and reduce sugar production, making it effective for metabolic health. The starting dose is 2.5 mg weekly, gradually increased for better control, but it's not for type 1 diabetes or diabetic ketoacidosis. 

Mounjaro 10 mg (tirzepatide) is primarily used for the treatment of type 2 diabetes mellitus and for chronic weight management in adults. It is a prescription medication that is administered as a once-weekly injection under the skin. 

Mounjaro 7.5 mg, containing tirzepatide, is used to improve blood sugar control in adults with type 2 diabetes and supports weight management in obese or overweight individuals, always alongside diet and exercise; it mimics natural hormones (GIP/GLP-1) to increase insulin, decrease appetite, slow digestion, and reduce sugar production, making it effective for metabolic health. The starting dose is 2.5 mg weekly, gradually increased for better control, but it's not for type 1 diabetes or diabetic ketoacidosis. 

Mounjaro 10 mg, containing tirzepatide, is used to improve blood sugar control in adults with type 2 diabetes and supports weight management in obese or overweight individuals, always alongside diet and exercise; it mimics natural hormones (GIP/GLP-1) to increase insulin, decrease appetite, slow digestion, and reduce sugar production, making it effective for metabolic health. The starting dose is 2.5 mg weekly, gradually increased for better control, but it's not for type 1 diabetes or diabetic ketoacidosis. 

Mounjaro 12.5 mg, containing tirzepatide, is used to improve blood sugar control in adults with type 2 diabetes and supports weight management in obese or overweight individuals, always alongside diet and exercise; it mimics natural hormones (GIP/GLP-1) to increase insulin, decrease appetite, slow digestion, and reduce sugar production, making it effective for metabolic health. The starting dose is 2.5 mg weekly, gradually increased for better control, but it's not for type 1 diabetes or diabetic ketoacidosis. 

Mounjaro 15 mg (tirzepatide) is primarily used for the treatment of type 2 diabetes mellitus and for chronic weight management in adults. It is a prescription medication that is administered as a once-weekly injection under the skin.